Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side-effects and impact on cost-effectiveness
Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side-effects and impact on cost-effectiveness
ชื่อเรื่อง :
Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side-effects and impact on cost-effectiveness
ปี :
2007
หมวด :
วิทยานิพนธ์
ผู้แต่ง :
Chuleegone Sornsuvit
ผู้แต่งร่วม :
-

Chuleegone Sornsuvit. 2007. Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side-effects and impact on cost-effectiveness. Field of Study Nutrition, Mahidol University;

Chuleegone Sornsuvit. (2007) Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side-effects and impact on cost-effectiveness . Mahidol University/Bangkok.

Chuleegone Sornsuvit. Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side-effects and impact on cost-effectiveness. . Bangkok:Mahidol University, 2007.

Chuleegone Sornsuvit. (2007) Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side-effects and impact on cost-effectiveness . Mahidol University/Bangkok.

เอกสารดาวน์โหลด
- ไม่พบเอกสารดิจิตอล -
จำนวนดาวน์โหลด
Abstract :
 0
Full-Text :
 0
Digital File :
 0
จำนวนดาวน์โหลดเพื่อใช้ประโยชน์
นโยบาย :
 0
วิชาการ :
 0
สังคม/ชุมชน :
 0
พาณิชย์/อุตสาหกรรม :
 0